Home > Financial Ratios > ANUH PHARMA

ANUH PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for ANUH PHARMA
Please provide your vote to see the results

ANUH PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 13.926.777.948.0112.17

What is the latest EV/Core EBITDA ratio of ANUH PHARMA ?

The latest EV/Core EBITDA ratio of ANUH PHARMA is 13.92 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202413.92
Mar20236.77
Mar20227.94
Mar20218.01
Mar202012.17

How is EV/Core EBITDA of ANUH PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 13.92
105.61
Mar2023 6.77
-14.74
Mar2022 7.94
-0.87
Mar2021 8.01
-34.18
Mar2020 12.17 -

Other Financial Ratios of ANUH PHARMA


Compare EV/Core EBITDA ratio of peers of ANUH PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ANUH PHARMA ₹945.9 Cr -8.9% -9.1% -11.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


ANUH PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ANUH PHARMA

-8.9%

-9.1%

-11.9%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses